Skip to main content
. 2012 Jun 14;23(11):2843–2851. doi: 10.1093/annonc/mds105

Table 3.

Sites of first disease-free survival (DFS) event according to histologic type and cohort

All patients (full cohort)
Patients with estrogen receptor- and grade 3 tumors (restricted cohort)
Medullary Ductal Medullary Ductal
Total patients 127 8096 47 1407
No DFS event 58 (46) 3577 (44) 26 (55) 642 (46)
Breast cancer-related DFS events 44 (35) 3770 (47) 14 (30) 674 (48)
 Local 6 (5) 666 (8) 0 94 (7)
 Contralateral breast 7 (6) 333 (4) 4 (9) 44 (3)
 Regional 8 (6) 493 (6) 5 (11) 116 (6)
Distant (as first site) 23 (18) 2278 (28) 5 (11) 420 (30)
 Distant soft tissue 4 (3) 129 (2) 0 33 (2)
 Bone 6 (5) 880 (11) 1 (2) 105 (7)
 Viscera 13 (10) 1269 (16) 4 (9) 282 (20)
Non-breast cancer-related events 25 (9) 749 (29) 7 (6) 91 (15)
 Second primary non-breast 12 (9) 362 (4) 3 (6) 49 (3)
 Death without prior cancer event 11 (9) 360 (4) 3 (6) 39 (3)
 Unknown 2 (2) 27 (0.3) 1 (2) 3 (0.2)